BACKGROUND: Although 3-dimensional echocardiography (3DE) has been applied during dobutamine echocardiography it has not been used during exercise echocardiography. We sought to compare feasibility and accuracy of 3DE and 2-dimensional echocardiography (2DE) during exercise echocardiography. METHODS: 100 patients underwent peak and postexercise (PEx) 2DE and 3DE on separate days. Coronary artery disease was detected in 58 patients. A quality score was calculated by assigning 0 to 3 points to each wall (apicoseptal, posterolateral, anterior, inferior). RESULTS: Feasibility of peak 2DE, peak 3DE, PEx 2DE, and PEx 3DE was 99%, 92%, 100%, and 95%, respectively (2DE at peak or PEx vs peak 3DE, P < .05). Agreement between 2DE and 3DE was 82% at peak (kappa = 0.62) and 78% at PEx (kappa = 0.55). Quality score less than 2 was seen in 4% of the walls with peak 2DE, in none with PEx 2DE, in 18% by peak 3DE, and in 14% by PEx 3DE. The mean quality score was lower with 3DE at peak and at PEx (2.4 +/- 0.9 vs 2.9 +/- 0.3; and 2.5 +/- 0.8 vs 3.0 +/- 0.1, both P < .0001). Acquisition time was shorter with 3DE at peak and PEx (22 +/- 8 vs 43 +/- 14 seconds; and 15 +/- 5 vs 31 +/- 14 seconds, both P < .0001). Sensitivity of peak 2DE, peak 3DE, PEx 2DE, and PEx 3DE was 84%, 78%, 71%, and 58%, respectively (P < .05 vs peak 3DE and peak 2DE). Specificity was 76%, 73%, 93%, and 88%, respectively. Accuracy for peak 2DE was 81% (area under the curve [AUC] 0.81, 95% confidence interval [CI] = 0.71-0.91); for peak 3DE was 76% (AUC 0.76, 95% CI = 0.65-0.86); for PEx 2DE was 80% (AUC 0.84, 95% CI = 0.75-0.92); and for PEx 3DE was 71% (AUC 0.73, 95% CI = 0.62-0.83). CONCLUSIONS: Three-dimensional echocardiography during exercise is comparable with 2DE in terms of sensitivity and specificity but feasibility is lower.
BACKGROUND: Although 3-dimensional echocardiography (3DE) has been applied during dobutamine echocardiography it has not been used during exercise echocardiography. We sought to compare feasibility and accuracy of 3DE and 2-dimensional echocardiography (2DE) during exercise echocardiography. METHODS: 100 patients underwent peak and postexercise (PEx) 2DE and 3DE on separate days. Coronary artery disease was detected in 58 patients. A quality score was calculated by assigning 0 to 3 points to each wall (apicoseptal, posterolateral, anterior, inferior). RESULTS: Feasibility of peak 2DE, peak 3DE, PEx 2DE, and PEx 3DE was 99%, 92%, 100%, and 95%, respectively (2DE at peak or PEx vs peak 3DE, P < .05). Agreement between 2DE and 3DE was 82% at peak (kappa = 0.62) and 78% at PEx (kappa = 0.55). Quality score less than 2 was seen in 4% of the walls with peak 2DE, in none with PEx 2DE, in 18% by peak 3DE, and in 14% by PEx 3DE. The mean quality score was lower with 3DE at peak and at PEx (2.4 +/- 0.9 vs 2.9 +/- 0.3; and 2.5 +/- 0.8 vs 3.0 +/- 0.1, both P < .0001). Acquisition time was shorter with 3DE at peak and PEx (22 +/- 8 vs 43 +/- 14 seconds; and 15 +/- 5 vs 31 +/- 14 seconds, both P < .0001). Sensitivity of peak 2DE, peak 3DE, PEx 2DE, and PEx 3DE was 84%, 78%, 71%, and 58%, respectively (P < .05 vs peak 3DE and peak 2DE). Specificity was 76%, 73%, 93%, and 88%, respectively. Accuracy for peak 2DE was 81% (area under the curve [AUC] 0.81, 95% confidence interval [CI] = 0.71-0.91); for peak 3DE was 76% (AUC 0.76, 95% CI = 0.65-0.86); for PEx 2DE was 80% (AUC 0.84, 95% CI = 0.75-0.92); and for PEx 3DE was 71% (AUC 0.73, 95% CI = 0.62-0.83). CONCLUSIONS: Three-dimensional echocardiography during exercise is comparable with 2DE in terms of sensitivity and specificity but feasibility is lower.
Authors: Senthil Selvaraj; Eva E Martinez; Frank G Aguilar; Kwang-Youn A Kim; Jie Peng; Jin Sha; Marguerite R Irvin; Cora E Lewis; Steven C Hunt; Donna K Arnett; Sanjiv J Shah Journal: Circ Cardiovasc Imaging Date: 2016-06 Impact factor: 7.792
Authors: Daniel H Katz; Senthil Selvaraj; Frank G Aguilar; Eva E Martinez; Lauren Beussink; Kwang-Youn A Kim; Jie Peng; Jin Sha; Marguerite R Irvin; John H Eckfeldt; Stephen T Turner; Barry I Freedman; Donna K Arnett; Sanjiv J Shah Journal: Circulation Date: 2013-09-27 Impact factor: 29.690
Authors: Daniel H Katz; Rahul C Deo; Frank G Aguilar; Senthil Selvaraj; Eva E Martinez; Lauren Beussink-Nelson; Kwang-Youn A Kim; Jie Peng; Marguerite R Irvin; Hemant Tiwari; D C Rao; Donna K Arnett; Sanjiv J Shah Journal: J Cardiovasc Transl Res Date: 2017-03-03 Impact factor: 4.132
Authors: Frank G Aguilar; Senthil Selvaraj; Eva E Martinez; Daniel H Katz; Lauren Beussink; Kwang-Youn A Kim; Jie Ping; Laura Rasmussen-Torvik; Amita Goyal; Jin Sha; Marguerite R Irvin; Donna K Arnett; Sanjiv J Shah Journal: Echocardiography Date: 2015-11-03 Impact factor: 1.724
Authors: Senthil Selvaraj; Frank G Aguilar; Eva E Martinez; Lauren Beussink; Kwang-Youn A Kim; Jie Peng; Daniel C Lee; Ateet Patel; Jin Sha; Marguerite R Irvin; Donna K Arnett; Sanjiv J Shah Journal: Cardiovasc Ultrasound Date: 2014-10-03 Impact factor: 2.062
Authors: Senthil Selvaraj; Frank G Aguilar; Eva E Martinez; Lauren Beussink; Kwang-Youn A Kim; Jie Peng; Laura Rasmussen-Torvik; Jin Sha; Marguerite R Irvin; C Charles Gu; Cora E Lewis; Steven C Hunt; Donna K Arnett; Sanjiv J Shah Journal: J Am Heart Assoc Date: 2014-04-29 Impact factor: 5.501
Authors: Senthil Selvaraj; Luc Djoussé; Frank G Aguilar; Eva E Martinez; Vincenzo B Polsinelli; Marguerite R Irvin; Donna K Arnett; Sanjiv J Shah Journal: J Am Coll Cardiol Date: 2017-08-08 Impact factor: 24.094
Authors: Sadiya S Khan; Kwang-Youn A Kim; Jie Peng; Frank G Aguilar; Senthil Selvaraj; Eva E Martinez; Abigail S Baldridge; Jin Sha; Marguerite R Irvin; Ulrich Broeckel; Donna K Arnett; Laura J Rasmussen-Torvik; Sanjiv J Shah Journal: Int J Cardiol Date: 2018-07-11 Impact factor: 4.039